Simplify Logo
BillionToOne

BillionToOne

Molecular diagnostics for prenatal and oncology testing

About

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair level, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne's business model centers on providing these diagnostic services directly to healthcare providers, generating revenue through the sale of their testing services. The goal of BillionToOne is to enhance the accuracy, efficiency, and accessibility of molecular testing, driven by a commitment to growth, equality, and teamwork in making a positive impact on healthcare.

Company Stage

Series C

Employees

201-500

Industries

Biotechnology, Healthcare

Total Funding

$295.9M

Headquarters

N/A

Founded

2016


Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $130M Series D funding round, led by PremjiInvest, positions BillionToOne for significant growth and expansion.
  • Partnerships with major companies like Johnson & Johnson enhance their credibility and market reach.
  • The appointment of Ross Taylor as CFO brings seasoned financial leadership, supporting the company's hypergrowth trajectory.

What critics are saying

  • The competitive landscape in molecular diagnostics is intense, requiring continuous innovation to maintain a leading position.
  • Dependence on healthcare providers for revenue could be impacted by changes in healthcare policies or economic downturns.

What makes BillionToOne unique

  • BillionToOne's QCT technology offers single base-pair resolution, providing unparalleled accuracy in molecular diagnostics.
  • Their focus on both prenatal screening and oncology testing allows them to address critical healthcare needs with specialized products like Northstar Select™ and Northstar Response™.
  • The company's mission-driven culture and commitment to accessibility set them apart in the biotech industry.

Help us improve and share your feedback! Did you find this helpful?


Growth & Insights
Headcount

6 month growth

13%

1 year growth

23%

2 year growth

74%

Benefits

Competitive pay

Retirement savings package

Parental leave

Free snacks & lunches

Medical, dental, & vision premiums

On campus perks

Free-on-site EV charging

Recently Posted Jobs

Sign up to get curated job recommendations

BillionToOne is Hiring for 0 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update BillionToOne's jobs every 8 hours, so check again soon! Browse all jobs →